BIOMAT Database Logo BIOMAT Database Logo

Insulin-like growth factor I levels during growth hormone (GH) replacement in GH-deficient adults: a gender difference. 2004

D V Soares, and F L Conceição, and R R L O Brasil, and L D C Spina, and P M Lobo, and E M C Silva, and A Buescu, and M Vaisman
Service of Endocrinology, Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Brazil. wellbs@terra.com.br

To evaluate the variation of serum IGF-1 levels during GH replacement and observe gender differences, 29 adults with GH deficiency (mean age 42.5 +/- 10.1 year), were studied. Serum IGF-1 was assessed every 4 weeks during the titration period and afterwards every 3 months of GH therapy. At baseline 77.7% of women and 45.4% of men had serum baseline IGF-1 levels below the lower limit of normal age-related reference range. The time to reach the maintenance dose was lower in men than women (p < 0.05). There was an increase in IGF-1 levels after one year of GH therapy, significant only in men (p < 0.01). IGF-1 concentrations were higher in men than women (p < 0.05), at the 12th and 18th months of GH therapy. GH dose was reduced by 25% in men (p < 0.01). At the end of the study the mean GH dose was lower in men than in women (p < 0.05). The factor responsible for these findings is not known, however a possible role of androgens has been suggested.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D V Soares, and F L Conceição, and R R L O Brasil, and L D C Spina, and P M Lobo, and E M C Silva, and A Buescu, and M Vaisman
Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
March 2000, The Journal of clinical endocrinology and metabolism,
D V Soares, and F L Conceição, and R R L O Brasil, and L D C Spina, and P M Lobo, and E M C Silva, and A Buescu, and M Vaisman
Effects of growth hormone (GH) and insulin-like growth factor-I on serum leptin in GH-deficient adults.
March 1997, Diabetologia,
D V Soares, and F L Conceição, and R R L O Brasil, and L D C Spina, and P M Lobo, and E M C Silva, and A Buescu, and M Vaisman
Increased orderliness of growth hormone (GH) secretion in GH-deficient adults with low serum insulin-like growth factor I.
June 2002, The Journal of clinical endocrinology and metabolism,
D V Soares, and F L Conceição, and R R L O Brasil, and L D C Spina, and P M Lobo, and E M C Silva, and A Buescu, and M Vaisman
Serum free insulin-like growth factor-I in growth hormone-deficient adults before and after growth hormone replacement.
August 1997, European journal of endocrinology,
D V Soares, and F L Conceição, and R R L O Brasil, and L D C Spina, and P M Lobo, and E M C Silva, and A Buescu, and M Vaisman
Gender difference in the response of growth hormone (GH)-deficient adults to GH therapy.
March 1999, Metabolism: clinical and experimental,
D V Soares, and F L Conceição, and R R L O Brasil, and L D C Spina, and P M Lobo, and E M C Silva, and A Buescu, and M Vaisman
Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids.
January 2004, Hormone research,
D V Soares, and F L Conceição, and R R L O Brasil, and L D C Spina, and P M Lobo, and E M C Silva, and A Buescu, and M Vaisman
Growth hormone (GH) regulation of circulating insulin-like growth factor-I levels during sexual maturation of the GH-deficient dwarf (dw/dw) male rat.
June 1994, The Journal of endocrinology,
D V Soares, and F L Conceição, and R R L O Brasil, and L D C Spina, and P M Lobo, and E M C Silva, and A Buescu, and M Vaisman
Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy.
January 1999, Journal of endocrinological investigation,
D V Soares, and F L Conceição, and R R L O Brasil, and L D C Spina, and P M Lobo, and E M C Silva, and A Buescu, and M Vaisman
Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults.
October 1997, The Journal of clinical endocrinology and metabolism,
D V Soares, and F L Conceição, and R R L O Brasil, and L D C Spina, and P M Lobo, and E M C Silva, and A Buescu, and M Vaisman
Growth hormone (GH) modulates insulin-like growth factor I (IGF-I) and type I IGF receptor mRNA levels in the ovary of prepubertal GH-deficient rats.
April 1995, European journal of endocrinology,
Copied contents to your clipboard!